Thu hồi 23 loại thuốc chứa dược chất nguy cơ gây ung thư
Cập nhật: 10:32 18/07/2018 GMT+7
PTĐT-Cục Quản lý dược (Bộ Y tế) ghi nhận có 23 loại thuốc trên thị trường trong nước chứa thành phần valsartan nguy cơ ung thư. Để đảm bảo an toàn cho người sử dụng, Cục Quản lý dược đình chỉ lưu hành 23 loại thuốc này.
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
Thu Trang